151 related articles for article (PubMed ID: 28815326)
1. A cross-sectional study on late taste disorders in survivors of allogeneic hematopoietic cell transplantation.
Sato T; Konuma T; Miwa Y; Sugihara N; Tsuru Y; Narita H; Kiriyama S; Kato S; Oiwa-Monna M; Kobayashi K; Takahashi S; Tojo A
Ann Hematol; 2017 Nov; 96(11):1841-1847. PubMed ID: 28815326
[TBL] [Abstract][Full Text] [Related]
2. Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation.
Majhail NS; Challa TR; Mulrooney DA; Baker KS; Burns LJ
Biol Blood Marrow Transplant; 2009 Sep; 15(9):1100-7. PubMed ID: 19660723
[TBL] [Abstract][Full Text] [Related]
3. Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase.
Goldman JM; Majhail NS; Klein JP; Wang Z; Sobocinski KA; Arora M; Horowitz MM; Rizzo JD
J Clin Oncol; 2010 Apr; 28(11):1888-95. PubMed ID: 20212247
[TBL] [Abstract][Full Text] [Related]
4. Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation.
Epstein JB; Phillips N; Parry J; Epstein MS; Nevill T; Stevenson-Moore P
Bone Marrow Transplant; 2002 Dec; 30(11):785-92. PubMed ID: 12439702
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of lung transplantation after allogeneic hematopoietic stem cell transplantation.
Cheng GS; Edelman JD; Madtes DK; Martin PJ; Flowers ME
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1169-75. PubMed ID: 24727334
[TBL] [Abstract][Full Text] [Related]
6. The experience of dysgeusia in allogeneic haematopoietic cell transplantation survivors: a qualitative study.
Bomben D; Bin A; Venturini M; Bulfone T; Ghirotto L; Bressan V
Support Care Cancer; 2019 Dec; 27(12):4607-4613. PubMed ID: 30937598
[TBL] [Abstract][Full Text] [Related]
7. Late taste disorders in bone marrow transplantation: clinical evaluation with taste solutions in autologous and allogeneic bone marrow recipients.
Marinone MG; Rizzoni D; Ferremi P; Rossi G; Izzi T; Brusotti C
Haematologica; 1991; 76(6):519-22. PubMed ID: 1820992
[TBL] [Abstract][Full Text] [Related]
8. Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation.
Al-Hazzouri A; Cao Q; Burns LJ; Weisdorf DJ; Majhail NS
Biol Blood Marrow Transplant; 2008 Jun; 14(6):658-63. PubMed ID: 18489991
[TBL] [Abstract][Full Text] [Related]
9. Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation.
Khera N; Storer B; Flowers ME; Carpenter PA; Inamoto Y; Sandmaier BM; Martin PJ; Lee SJ
J Clin Oncol; 2012 Jan; 30(1):71-7. PubMed ID: 22147737
[TBL] [Abstract][Full Text] [Related]
10. The management of gynecological complications in long-term survivors after allogeneic hematopoietic cell transplantation-a single-center real-life experience.
Klasa Ł; Sadowska-Klasa A; Piekarska A; Wydra D; Zaucha JM
Ann Hematol; 2020 Jun; 99(6):1361-1368. PubMed ID: 32342133
[TBL] [Abstract][Full Text] [Related]
11. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
12. Impact of cGVHD on socioeconomic outcomes in survivors with pediatric hematopoietic stem cell transplant in Japan: a cross-sectional observational study.
Soejima T; Shiohara M; Ishida Y; Inoue M; Hayakawa A; Sato A; Kamibeppu K; Atsuta Y; Yamashita T
Int J Hematol; 2021 Apr; 113(4):566-575. PubMed ID: 33386599
[TBL] [Abstract][Full Text] [Related]
13. Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: a single-center experience.
Vogl UM; Nagayama K; Bojic M; Hoda MA; Klepetko W; Jaksch P; Dekan S; Siersch V; Mitterbauer M; Schellongowski P; Greinix HT; Petkov V; Schulenburg A; Kalhs P; Rabitsch W
Transplantation; 2013 Feb; 95(4):623-8. PubMed ID: 23274967
[TBL] [Abstract][Full Text] [Related]
14. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.
Ando M; Ohashi K; Akiyama H; Sakamaki H; Morito T; Tsuchiya K; Nitta K
Nephrol Dial Transplant; 2010 Jan; 25(1):278-82. PubMed ID: 19762604
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for depression and fatigue among survivors of hematopoietic cell transplantation.
Jim HS; Sutton SK; Jacobsen PB; Martin PJ; Flowers ME; Lee SJ
Cancer; 2016 Apr; 122(8):1290-7. PubMed ID: 26814442
[TBL] [Abstract][Full Text] [Related]
16. Association of oral toxicity and taste changes during hematopoietic stem cell transplantation: a preliminary study.
Ferreira MH; Mello Bezinelli L; de Paula Eduardo F; Lopes RM; Pereira AZ; Hamerschlack N; Corrêa L
Support Care Cancer; 2020 Mar; 28(3):1277-1287. PubMed ID: 31236700
[TBL] [Abstract][Full Text] [Related]
17. Morbidity and Mortality Differences Between Hematopoietic Cell Transplantation Survivors and Other Cancer Survivors.
Chow EJ; Cushing-Haugen KL; Cheng GS; Boeckh M; Khera N; Lee SJ; Leisenring WM; Martin PJ; Mueller BA; Schwartz SM; Baker KS
J Clin Oncol; 2017 Jan; 35(3):306-313. PubMed ID: 27870568
[TBL] [Abstract][Full Text] [Related]
18. Relative survival of long-term hematopoietic cell transplant recipients approaches general population rates.
Nivison-Smith I; Simpson JM; Dodds AJ; Ma DD; Szer J; Bradstock KF
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1323-30. PubMed ID: 19747641
[TBL] [Abstract][Full Text] [Related]
19. Incidence and predictors of recurrent sick leave in survivors who returned to work after allogeneic hematopoietic cell transplantation.
Kurosawa S; Yamaguchi T; Mori A; Matsuura T; Masuko M; Murata M; Tashiro H; Kako S; Satake A; Hagihara M; Ota S; Saito T; Kagawa K; Matsuo Y; Itonaga H; Uoshima N; Yamaguchi H; Naito K; Takahashi M; Fukuda T
J Cancer Surviv; 2023 Jun; 17(3):781-794. PubMed ID: 36048313
[TBL] [Abstract][Full Text] [Related]
20. Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States.
Bhatt NS; Brazauskas R; Salit RB; Syrjala K; Bo-Subait S; Tecca H; Badawy SM; Baker KS; Beitinjaneh A; Bejanyan N; Byrne M; Dias A; Farhadfar N; Freytes CO; Ganguly S; Hashmi S; Hayashi RJ; Hong S; Inamoto Y; Jamani K; Kasow KA; Khera N; Krem MM; Lazarus HM; Lee CJ; Lee S; Majhail NS; Malone AK; Marks DI; Mau LW; Mayo SJ; Muffly LS; Nathan S; Nishihori T; Page KM; Preussler J; Rangarajan HG; Rotz SJ; Salooja N; Savani BN; Schears R; Schechter-Finkelstein T; Schiller G; Shah AJ; Sharma A; Wang T; Wirk B; Battiwalla M; Schoemans H; Hamilton B; Buchbinder D; Phelan R; Shaw B
Transplant Cell Ther; 2021 Aug; 27(8):679.e1-679.e8. PubMed ID: 33895402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
